Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes

Fundamental and Clinical Pharmacology

Volumn 21, Issue 5, 2007, Pages 521-529

  Bishnoi, Mahendra ^a   Chopra, Kanwaljit ^b   Kulkarni, Shrinivas K ^a,b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Oxidative damage; Receptor sensitivity; Rutin; Tardive dyskinesia

Indexed keywords

CATALASE; DOPAMINE; DOPAMINE RECEPTOR; FLAVONOID; GLUTATHIONE; HALOPERIDOL; LIPID; NEUROTRANSMITTER; NORADRENALIN; POLYPHENOL DERIVATIVE; RUTOSIDE; SUPEROXIDE DISMUTASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; LOCOMOTION; MALE; MASTICATION; MAZE TEST; MOTOR DYSFUNCTION; MOUSE; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; OROFACIAL DYSKINESIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REARING; TONGUE; TREATMENT OUTCOME;

AKATHISIA, DRUG-INDUCED; ANIMALS; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; FLAVONOIDS; GLUTATHIONE; HALOPERIDOL; LIPID PEROXIDATION; MALE; MASTICATION; MAZE LEARNING; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RUTIN; STEREOTYPED BEHAVIOR;

EID: 34548613764     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00512.x     Document Type: Article

References (40)

1. Grohman R., Koch R., Schmidt L.G. Extrapyramidal symptoms in neuroleptic recipients, in : Adverse drug reactions, Birkhauser Verlag, Basel, 1990, pp. 71 82.
2. Casey D.E. Tardive dyskinesia: pathophysiology and animal models. J. Clin. Psychiatry (2000) 61 5 9.
3. Balijepalli S., Kenchappa R.S., Boyd M.R., Ravindranath V. Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics. Neurochem. Int. (2001) 38 425 435.
4. Andreassen O.A., Jorgensen H.A. Neurotoxicity associated with neuroleptic induced oral dyskinesias in rats implications for tardive dyskinesia? Prog. Neurobiol. (2000) 61 525 541.
5. Cadet J.L., Lohr J.B., Jeste D.V. Free radicals and tardive dyskinesia. Trends Neurosci. (1986) 9 107 108.
6. Soares K.V., Mcgrath J.J. Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst. Rev. (2000) 2, CD 000209.
7. Harborne J.B. Plant phenolics, in : Bell E.A., Charlwood B.V. (Eds Encyclopedia of plant physiology, Vol 8. Secondary plant products, Springer Verlag, Berlin, Germany. 1986, pp. 329 395.
8. Cos P., Ying L., Calomme M. et al. Structure activity relationship and classification of flavanoids as inhibitor of xanthine oxidase and superoxide scavengers. J. Nat. Prod. (1998) 61 71 76.
9. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavanoids and their determinants in adults in The Netherlands. Nutr. Cancer (1993) 20 21 29.
10. Janbaz K.H., Saeed S.A., Gilani A.H. Protective effect of rutin on paracetamol and CCl4-induced hepatotoxicity in rodents. Fitoterapia (2002) 73 557 563.
11. Cotelle N. Role of flavanoids in oxidative stress. Curr. Top. Med. Chem. (2001) 1 569 590.
12. Rice Evans C. Flavanoid antioxidants. Curr. Med. Chem. (2001) 8 797 807.
13. Naidu P.S., Singh A., Kulkarni S.K. Quercetin, a bioflavonoid attenuated haloperidol induced orofacial dyskinesia. Neuropharmacology (2003) 44 1100 1106.
14. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine induced learning impairment. Brain Res. (1998) 799 215 219.
15. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus maze for dissociation of amnesic and behavioural effects of drugs in mice. Eur. J. Pharmacol. (1994) 1991 71 76.
16. Kulkarni S.K. Handbook of experimental pharmacology, 3rd edn. Vallabh Prakashan, New Delhi, India. 1999.
17. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. (1965) 99 667 676.
18. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. (1959) 82 70 77.
19. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch. Biochem. Biophys. (1978) 186 189 195.
20. Luck H. Catalase spectrophotometric method. Methods in enzymatic analysis. Academic Press, New York, 1963.
21. Lowry O.H., Rosenbrought N.J., Farr A.L., Randall R.J. Protein measurements with the Folin-phenol reagent. J. Biol. Chem. (1951) 193 265 275.
22. Church W.H. Column chromatography analysis of brain tissue: an advanced laboratory exercise for neuroscience majors. J. Undergraduate Neurosci. Educ. (2005) 3 A36 A41.
23. Shivakumar B.R., Ravindranath V. Oxidative stress and thiol modification induced by chronic administration of haloperidol. J. Pharmacol. Exp. Ther. (1993) 265 1137 1141.
24. Elkashef A.M., Wyatt J. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. Schizophr. Bull. (1997) 25 731 740.
25. Singh A., Naidu P.S., Kulkarni S.K. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia. Eur. J. Pharmacol. (2003) 477 87 94.
26. Tsai G.C., Golf D.C., Chang R.W., Flood J., Baer L., Coyle J.T. Markers of glutamatergic transmission and oxidative stress associated with tardive dyskinesia. Am. J. Psychiatry (1998) 155 1207 1213.
27. Burger M.B.E., Fachineto R., Alves A., Callegari L., Rocha J.B.T. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res. (2005) 1031 202.
28. Negre-Salvayre A., Affany A., Hariton C., Salvayre R. Additional antilipoperoxidant activities pf alpha tocopherol and ascorbic acid on membrane like systems are potentiated by rutin. Pharmacology (1991) 42 262 272.
29. Kozlov A.V., Ostrachovitch E.A., Afanas'ev I.B. Mechanism of inhibitory effect of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem. Pharmacol. (1994) 47 795 799.
30. Nakamura Y., Ishimitsu S., Tonogai Y. Effects of quercetin and rutin on serum and hepatic lipid concentrations, fecal steroid excretion and serum antioxidant properties. J. Health Sci. (2000) 46 229 240.
31. Zeilinska M., Kostrzewa A., Ignatowicz E., Budzianowski J. The flavanoids quercetin and isorhamnetin3-O-acyl glucosides diminish neutrophils oxidative metabolism and lipid peroxidation. Acta Biochem. Pol. (2001) 48 183 189.
32. Nagata H., Takekoshi S., Honma T., Watanable K. Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase. Tokai J. Exp. Clin. Med. (1999) 24 1 11.
33. Fiorani M., De Sanctis R., Menghinello P., Cucchiarini L., Cellini B., Dacha M. Quercetin prevents glutathione depletion induced by dehydroascorbbic acid in rabbit red blood cells. Free Radic. Res. (2001) 34 639 648.
34. Erden I.M., Kahraman A., Koken T. Beneficial effects of quercetin on oxidative stress induced by Ultraviolet A. Clin. Exp. Dermatol. (2001) 26 536 539.
35. Sanderson J., Mc Lauchlan W.R., Williamson G. Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens. Free Radic. Biol. Med. (1999) 26 639 645.
36. Lee M.H., Lin R.D., Shen L.Y., Yang Y.Y., Yen K.Y., Hou W.C. Monoamino oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. J. Agric. Food Chem. (2001) 49 5551 5555.
37. Bishnoi M., Chopra K., Kulkarni S.K. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Eur. J. Pharmacol. (2006) 552 55 66.
38. Lau Y.S., Petroske E., Meredith G.E., Wang J.Q. Elevated neuronal nitric oxide synthase expression in chronic haloperidol treated rats. Neuropharmacology (2003) 45 986 994.
39. Boyle S.P., Dobson V.L., Duthie S.J., Hinselwood D.C., Kyle J.A.M., Collins A.R. Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. Eur. J. Clin. Nutr. (2000) 54 774 782.
40. Erlund I., Kosonen T., Alfthan G., Pertunnen K.M., Kenralli J., Parantainen J. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. (2000) 56 545 553.